Abstract
Imidazolyl substituted 16E-arylidenosteroidal derivatives have been synthesized and evaluated for aromatase inhibitory activity. The steroidal hybrids displayed moderate inhibition of the aromatase enzyme. The enzyme activity was monitored by measuring the tritiated H2O released from [1β-3H] androstenedione during aromatization. 16-[3-{3-(Imidazol-1-yl)propoxy}benzylidene]-4-androstene-3,17-dione (10, IC50: 4.4 μM) was found to be seven times more potent in comparison to standard drug aminoglutethimide. New imidazolyl substituted 16E-arylidenosteroidal derivatives have been synthesized and evaluated for aromatase inhibitory activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
